Anupam Kotwal Selected Research

Anupam Kotwal Research Topics

Disease

12	Neoplasms (Cancer) 03/2024 - 01/2019
4	Thyroid Neoplasms (Thyroid Cancer) 01/2024 - 07/2018
4	Hypothyroidism 01/2023 - 12/2018
4	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2023 - 01/2021
3	Hypophysitis 01/2023 - 01/2021
3	Thyroiditis 10/2021 - 01/2020
3	Graves Disease (Basedow Disease) 12/2020 - 07/2018
3	Thyrotoxicosis 01/2020 - 07/2018
3	Graves Ophthalmopathy 01/2019 - 07/2018
2	Hypopituitarism (Sheehan's Syndrome) 01/2022 - 01/2021
2	Hyperthyroidism 12/2020 - 12/2018
2	Cardiac Arrhythmias (Arrythmia) 12/2020 - 11/2018
2	Myxedema 01/2019 - 07/2018
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 01/2017
1	Lymphatic Metastasis 01/2024
1	Thyroid Nodule (Nodule, Thyroid) 01/2024
1	Hypokalemia 11/2022
1	Adrenocortical Carcinoma 11/2022
1	Cushing Syndrome 11/2022
1	Insulin Resistance 12/2021
1	Hyperglycemia 12/2021
1	Fatigue 01/2021
1	Asthenia 01/2021
1	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Hypercholesterolemia 12/2020
1	Hypertriglyceridemia 12/2020
1	Hypoparathyroidism 12/2020
1	Enthesopathy 01/2020
1	Primary Hyperparathyroidism 01/2020
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2019
1	Thrombophlebitis 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Elephantiasis 01/2019
1	Heart Diseases (Heart Disease) 11/2018
1	Hematoma 11/2018
1	Hypocalcemia 11/2018
1	Osteopoikilosis 01/2017
1	Melorheostosis 01/2017
1	Hypoglycemia (Reactive Hypoglycemia) 01/2017

Drug/Important Bio-Agent (IBA)

13	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2019
4	GlucocorticoidsIBA 01/2023 - 12/2018
4	Insulin (Novolin)FDA Link 01/2023 - 01/2017
3	IodineIBA 01/2022 - 12/2018
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
2	AntibodiesIBA 01/2020 - 07/2018
1	Mitotane (Lysodren)FDA Link 11/2022
1	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2022
1	Fumarate Hydratase (Fumarase)IBA 11/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	NivolumabIBA 01/2022
1	IpilimumabIBA 01/2022
1	pembrolizumabIBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2021
1	CytokinesIBA 10/2021
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2021
1	SilverIBA 01/2021
1	trans-crotonin (CTN)IBA 01/2021
1	Carcinoembryonic AntigenIBA 01/2021
1	Apolipoproteins AIBA 12/2020
1	ApolipoproteinsIBA 12/2020
1	CholesterolIBA 12/2020
1	LipidsIBA 12/2020
1	Thyroxine (Levothyroxine)FDA LinkGeneric 12/2020
1	Lipoprotein(a)IBA 12/2020
1	oxidized low density lipoproteinIBA 12/2020
1	LDL CholesterolIBA 12/2020
1	HDL CholesterolIBA 12/2020
1	Triglycerides (Triacylglycerol)IBA 12/2020
1	Apolipoproteins B (ApoB)IBA 12/2020
1	Apoprotein(a) (Apolipoprotein (a))IBA 12/2020
1	atezolizumabIBA 01/2020
1	avelumabIBA 01/2020
1	MineralsIBA 01/2020
1	Thyroid HormonesIBA 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020
1	C-PeptideIBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019
1	Antithyroid Agents (Antithyroid Drugs)IBA 12/2018
1	SeleniumIBA 12/2018
1	Amiodarone (Amiodarona)FDA LinkGeneric 11/2018
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 07/2018
1	AutoantibodiesIBA 07/2018
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2017
1	Blood Glucose (Blood Sugar)IBA 01/2017
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2017

Therapy/Procedure

14	Therapeutics 01/2024 - 11/2014
6	Thyroidectomy 01/2024 - 11/2018
2	Glycemic Control 11/2022 - 01/2017
1	Immunotherapy 01/2023
1	Aftercare (After-Treatment) 12/2020
1	Immunomodulation 10/2020
1	Parathyroidectomy 01/2020
1	Radiotherapy 12/2018
1	Patient Readmission 11/2018